![Claude Bertrand - SERVIER : "Etre engagés pour le progrès thérapeutique au bénéfice des patients" - YouTube Claude Bertrand - SERVIER : "Etre engagés pour le progrès thérapeutique au bénéfice des patients" - YouTube](https://i.ytimg.com/vi/S1cVDdNTaxU/maxresdefault.jpg)
Claude Bertrand - SERVIER : "Etre engagés pour le progrès thérapeutique au bénéfice des patients" - YouTube
![Passion and Purpose - Thom Dennis interviews Claude Bertrand, the EVP R&D & CSO of Servier - YouTube Passion and Purpose - Thom Dennis interviews Claude Bertrand, the EVP R&D & CSO of Servier - YouTube](https://i.ytimg.com/vi/p1OYRfQFmNU/maxresdefault.jpg)
Passion and Purpose - Thom Dennis interviews Claude Bertrand, the EVP R&D & CSO of Servier - YouTube
Servier Pharmaceuticals on LinkedIn: Last Thursday, Olivier Laureau, David K. Lee and Claude Bertrand…
![Servier unveils cancer-focused Seaport R&D campus to research oncology drugs - Boston Business Journal Servier unveils cancer-focused Seaport R&D campus to research oncology drugs - Boston Business Journal](https://content-thumbnail.cxpublic.com/content/dominantthumbnail/9784f70c725e6a49d810f9abc207e0eab9969920.jpg?63ed06c1)
Servier unveils cancer-focused Seaport R&D campus to research oncology drugs - Boston Business Journal
Servier on Twitter: "@Bertran16Claude [Focus Australia] 🇦🇺 The International Center for Therapeutic Research (ICTR) was established in 1999. It was the first Servier international centre for therapeutic research to open its doors
![Servier on Twitter: "We are always exploring different ways to serve patients' needs. This includes #research & #development of monoclonal antibodies to fight against #cancer. Learn more about our latest announcements👉https://t.co/Q84thhbOsh https ... Servier on Twitter: "We are always exploring different ways to serve patients' needs. This includes #research & #development of monoclonal antibodies to fight against #cancer. Learn more about our latest announcements👉https://t.co/Q84thhbOsh https ...](https://pbs.twimg.com/media/EZrDTrZX0AU2ZKU.jpg)